Compare ATEN & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATEN | ATRC |
|---|---|---|
| Founded | 2004 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.4B |
| IPO Year | 2014 | 2005 |
| Metric | ATEN | ATRC |
|---|---|---|
| Price | $23.88 | $29.02 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 7 |
| Target Price | $24.00 | ★ $51.17 |
| AVG Volume (30 Days) | ★ 800.9K | 493.0K |
| Earning Date | 04-30-2026 | 04-28-2026 |
| Dividend Yield | ★ 1.00% | N/A |
| EPS Growth | N/A | ★ 74.74 |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $235,429,000.00 | $201,630,000.00 |
| Revenue This Year | $13.02 | $15.27 |
| Revenue Next Year | $10.39 | $12.21 |
| P/E Ratio | $42.07 | ★ N/A |
| Revenue Growth | 2.36 | ★ 15.40 |
| 52 Week Low | $13.81 | $27.31 |
| 52 Week High | $24.22 | $43.18 |
| Indicator | ATEN | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 71.22 | 42.11 |
| Support Level | $17.12 | $28.60 |
| Resistance Level | N/A | $30.90 |
| Average True Range (ATR) | 0.71 | 1.13 |
| MACD | 0.14 | 0.14 |
| Stochastic Oscillator | 93.78 | 46.11 |
A10 Networks Inc is a provider of security and infrastructure solutions for on-premises, hybrid cloud, and edge-cloud environments of its multinational enterprise, communication, cloud and web service provider customers who strive to provide business-critical applications and networks that are secure, available, and efficient. As cyber-attacks increase in volume and complexity, the company integrates security and artificial intelligence (AI) enabled capabilities in its solutions that enable its customers to continue to adapt to market trends in hybrid cloud, AI-ready data centers and the ever-increasing need for high-performance, high availability and low latency. The company generates the maximum of its revenue from Americas.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.